|
gptkbp:instanceOf
|
gptkb:chemical_compound
|
|
gptkbp:ATCCode
|
M01AE01
|
|
gptkbp:bioavailability
|
80-100%
|
|
gptkbp:CASNumber
|
15687-27-1
|
|
gptkbp:contraindication
|
Peptic ulcer
Hypersensitivity to NSAIDs
Severe heart failure
|
|
gptkbp:drugClass
|
analgesic
Antipyretic
nonsteroidal anti-inflammatory drug
|
|
gptkbp:eliminationHalfLife
|
1.8-2 hours
|
|
gptkbp:excretion
|
Renal
|
|
gptkbp:hasInChIKey
|
HEFNNWSXXWATRW-UHFFFAOYSA-N
|
|
gptkbp:hasMolecularFormula
|
C13H18O2
|
|
gptkbp:hasSMILES
|
CC(C)CC1=CC=C(C=C1)C(C)C(=O)O
|
|
gptkbp:hasUNII
|
WK2XYI10QM
|
|
gptkbp:hasWikipediaPage
|
https://en.wikipedia.org/wiki/Ibuprofen
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
CHEMBL905
|
|
gptkbp:indication
|
gptkb:Pain
Fever
Inflammation
|
|
gptkbp:isApprovedDrug
|
true
|
|
gptkbp:legalStatus
|
gptkb:OTC
|
|
gptkbp:mechanismOfAction
|
Inhibits cyclooxygenase (COX-1 and COX-2)
|
|
gptkbp:metabolism
|
Liver
|
|
gptkbp:molecularWeight
|
206.28
|
|
gptkbp:name
|
gptkb:Ibuprofen
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:PubChem_CID
|
gptkb:DB01050
3672
D00126
CHEBI:5855
|
|
gptkbp:routeOfAdministration
|
gptkb:Oral
Intravenous
Topical
|
|
gptkbp:sideEffect
|
gptkb:Nausea
Dizziness
Rash
Gastrointestinal irritation
|
|
gptkbp:synonym
|
gptkb:Nurofen
gptkb:Motrin
gptkb:Advil
gptkb:Brufen
|
|
gptkbp:target
|
gptkb:Prostaglandin-endoperoxide_synthase_2
gptkb:Prostaglandin-endoperoxide_synthase_1
|
|
gptkbp:therapeuticArea
|
gptkb:Nervous_system
Musculoskeletal system
Antiinflammatory and antirheumatic products
|
|
gptkbp:bfsParent
|
gptkb:D006_Heroin
|
|
gptkbp:bfsLayer
|
7
|